1. Home
  2. ANSC vs SIGA Comparison

ANSC vs SIGA Comparison

Compare ANSC & SIGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANSC
  • SIGA
  • Stock Information
  • Founded
  • ANSC 2021
  • SIGA 1995
  • Country
  • ANSC United States
  • SIGA United States
  • Employees
  • ANSC N/A
  • SIGA N/A
  • Industry
  • ANSC
  • SIGA Biotechnology: Pharmaceutical Preparations
  • Sector
  • ANSC
  • SIGA Health Care
  • Exchange
  • ANSC Nasdaq
  • SIGA Nasdaq
  • Market Cap
  • ANSC 463.6M
  • SIGA 422.9M
  • IPO Year
  • ANSC 2023
  • SIGA 1997
  • Fundamental
  • Price
  • ANSC $10.76
  • SIGA $6.15
  • Analyst Decision
  • ANSC
  • SIGA
  • Analyst Count
  • ANSC 0
  • SIGA 0
  • Target Price
  • ANSC N/A
  • SIGA N/A
  • AVG Volume (30 Days)
  • ANSC 83.0K
  • SIGA 429.7K
  • Earning Date
  • ANSC 01-01-0001
  • SIGA 05-08-2025
  • Dividend Yield
  • ANSC N/A
  • SIGA 9.67%
  • EPS Growth
  • ANSC N/A
  • SIGA N/A
  • EPS
  • ANSC 0.19
  • SIGA 0.67
  • Revenue
  • ANSC N/A
  • SIGA $120,330,310.00
  • Revenue This Year
  • ANSC N/A
  • SIGA N/A
  • Revenue Next Year
  • ANSC N/A
  • SIGA $95.31
  • P/E Ratio
  • ANSC $56.23
  • SIGA $9.25
  • Revenue Growth
  • ANSC N/A
  • SIGA N/A
  • 52 Week Low
  • ANSC $10.23
  • SIGA $4.95
  • 52 Week High
  • ANSC $10.78
  • SIGA $12.83
  • Technical
  • Relative Strength Index (RSI)
  • ANSC 72.90
  • SIGA 55.99
  • Support Level
  • ANSC $10.73
  • SIGA $5.90
  • Resistance Level
  • ANSC $10.74
  • SIGA $6.23
  • Average True Range (ATR)
  • ANSC 0.00
  • SIGA 0.21
  • MACD
  • ANSC -0.00
  • SIGA 0.02
  • Stochastic Oscillator
  • ANSC 100.00
  • SIGA 78.57

About ANSC Agriculture & Natural Solutions Acquisition Corporation

Agriculture & Natural Solutions Acquisition Corp is a blank check company.

About SIGA SIGA Technologies Inc.

SIGA Technologies Inc is a commercial-stage pharmaceutical company focused on the health security market. The company's main product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by the variola virus. The company derives maximum revenue from United States.

Share on Social Networks: